Arailym Nurpeissova, CEAMS, NLA to win  TechWomen grant  in Silicon Valley

Arailym Nurpeissova, CEAMS, NLA to win  TechWomen grant  in Silicon Valley

October 25, 2018

This year five girls from Kazakhstan, among them is Arailym Nurpeissova, were selected out of  3 300 applicants from  Central Asia, the Middle East and Africa by experts of Institute of International Education (IIE), which is  managing TechWomen.

During the five-week program, all participants engaged in project-based mentorships at leading companies in the San Francisco Bay Area and Silicon Valley, participated in professional development workshops and networking events, and traveled to Washington, D.C. for targeted meetings and special events to conclude the program.

On October 19, all participants presented their projects in Silicon Valley on solving socially significant problems in their countries like poverty, illiteracy, poor quality of medical services, environmental pollution and so on. The team from Kazakhstan came up with the idea of ​​creating an online platform “” on the issue of domestic violence.

The goal of the Kazakhstani  project is to create an information environment for raising public awareness of victims of domestic violence, obtaining legal and psychological assistance for  victims, and creating a society of mutual support. The girls analyzed that annually in Kazakhstan the number of deaths of women from domestic violence ranges from 400 to 500 people, so girls decided to take as an example the experience of the American company “Madre” in California. This organization, which protects victims of violence, has been able to reduce the mortality rate of women over the past 10 years and bring it to a minimum so that the number of women who die from domestic violence has become 0.   

It is know, that the mission of TechWomen is to empower, connect and support the next generation of women leaders in science, technology, engineering and mathematics (STEM) by providing them access and opportunity to advance their careers, pursue their dreams, and become role models for women and girls in their communities.

TechWomen is an initiative of the U.S. Department of State’s Bureau of Educational and Cultural Affairs (ECA). TechWomen, launched in 2011, supports the United States’ global commitment toward advancing the rights and participation of women and girls around the world by enabling them to reach their full potential in the tech industry.

Sino-French-Kazakh Workshop on Innovative Therapeutic Solutions for Cancer and Ageing diseases at NU

Sino-French-Kazakh Workshop on Innovative Therapeutic Solutions for Cancer and Ageing diseases at NU

October 23, 2018

Sino-French workshopOn October 18-19 researchers of NLA took part at the Sino-French-Kazakh Workshop on Innovative Therapeutic Solutions for Cancer and Ageing diseases, that was organized by International Bio-Business Services (IBBS) with the support of the French Embassy in Kazakhstan, Nazarbayev University and the Sino-French School of Oncology.

The workshop brought together Kazakh, Chinese and French participants from academic and medical institutions as well as industrial players to share their views and knowledge in order to strengthen international cooperation and establish new interactive programs.

Ainur Akilzhanova, head of Laboratory of Genomic and Personalized Medicine, NLA and Ulykbek Kairov, head of Laboratory of Bioinformatics and Computational Systems Biology, NLA  presented their research on clinical interpretation and implications of whole genome/ whole exome sequencing for cancer and aging diseases.

Whole-genome sequencing (WGS) and whole exome sequencing (WES) are increasingly applied in clinical medicine and is expected to uncover clinically significant findings regardless of sequencing indication. The promise of personalized medicine depends on the ability to integrate genetic sequencing information into disease risk assessment for individuals. Genomic sequencing technology is moving rapidly from the research setting into clinical medicine but significant technological and interpretive challenges remain.

Aim of this study was to evaluate the clinical utility of WGS/WES in a group of healthy Kazakh population regarding the detection of genetic variants associated with predisposition to various clinical conditions and drug response.

Researchers presented findings from an exploratory study of 115 participants, most of whom identified themselves as Kazakh (up to at list 3 generations). Participants aged 18-65 years answered questions about the reasons they consented to study and about what they anticipated would come of genomic sequencing, demographic data, risk factors, family history and ancestry questions. None of the study participants had manifest inherited disease. gDNA was extracted from blood. DNA libraries were performed using Nextera DNA Library Preparation Kit (Illumina, USA). For WES gDNA was fragmented, then DNA libraries were performed using SureSelect Human All Exon V5+UTRs kit (Agilent Technologies). Sequencing was performed on Illumina HiSeq2000 platform with min coverage 30x (WGS) and 100x(WES). Bioinformatic analysis was done. Data was compared with data of existing international databases (COSMIC, ESP600, ClinVar, PharmGKB etc) to identify clinical genomic variants in our data. Mendelian variants were compared with ACMG-reportable genes, HGMD. Molecular diagnostics requires accurate and consistent classification of sequence variants (i.e., single nucleotide variants (SNVs) and deletion/insertion (indels) variants). Detection of a pathogenic or “actionable” variant may influence a patient's diagnosis and/or prognosis, family planning, and lifelong health management.

Several genetic variants with clinical implications were identified in all healthy participants. Detected variants are presented grouped into categories in the report delivered to healthy person – predisposition to clinical conditions, inherited disorders (if any), cancer, cardiovascular risks, drug response etc. More promising using targeted NGS for molecular characterization of cancer and aging disease. Compared to broader approaches, such as WGS, targeted sequencing is a more cost-effective method for investigating areas of interest. Targeted resequencing enables researchers to focus on regions that are most likely to be involved in the phenotype under study, conserving resources and generating a smaller, more manageable data set. Targeted approaches can also deliver much higher coverage levels, allowing identification of variants that are rare and more expensive with whole-genome or Sanger sequencing.

WGS/WES seems be the method of choice not only in cases with a specific clinical phenotype in need of reaching a diagnosis but also in the context of carrier screening. The disclosure of the NGS results to the patient is not an issue, if genetic counseling by a healthcare provider with genetic background is provided before and after test according to international guidelines. Targeted approaches using next-generation sequencing (NGS) allow researchers to focus time, expenses, and data analysis on specific areas of interest.

During the Sino-French-Kazakh Workshop were presented also reports  on the possible applications of electromagnetic fields for cancer treatment (Dinara Begimbetova, senior researcher, Laboratory of Translational Medicine and Life Sciences Technologies, NLA), reports on robust approach for analysis and interpretation of tumor transcriptomes from high-throughput genomic platforms for investigation of hidden signals (Ulykbek Kairov, Laboratory of Bioinformatics and Computational Systems Biology, NLA) and others.    

NLA researchers  to win  National Competition on Innovations

NLA researchers to win National Competition on Innovations

October 18, 2018

 The  initiative scientific research results of NLA researchers from the Laboratory of Bioengineering and Regenerative Medicine was recognized as one of the most innovative by the results of the 2018 National Competition of Innovations and the rating of innovative companies.

The cash prize as the second place holders in the amount of 800 thousand tenge was awarded to our scientists in the nomination “The best technological solution among startups”. The national innovation competition was held under the auspices of the National Agency for Technological Development, JSC with the support of the Ministry of Investment and Development of the Republic of Kazakhstan. The winners of the competition were determined by an independent commission from among the authoritative leaders of the startup ecosystem of Kazakhstan, as well as a commission from among the heads of republican mass-media.

According to Sholpan Askarova, Head of the Laboratory of Bioengineering and Regenerative Medicine, who is also the head of the start-up team of the “AstanaBiomedGroup”, they won the jury awards for developing the topical  remedy for psoriasis “A-psorin”.

 -Psoriasis is a chronic and widespread skin disease that affects both men and women of all ages, regardless of ethnicity, in all countries of the world. We developed and tested a thermosensitive hydrogel for the treatment of vulgar (simple) psoriasis, containing poloxamer 407 and polyethylene glycol as the basis for and auxiliary substances, characterized in that 6-aminohexanoic acid, belonging to the group of fibrinolysis inhibitors, is used as an active substance,- said Sholpan Askarova .

In the near future, as scientists expect, “A-psorin” will be released not only in Kazakhstan, but also in the Eurasian market. Now they are actively working on this in “AstanaBiomedGroup”.

Green Energy and Municipal Solid Waste Solutions

Green Energy and Municipal Solid Waste Solutions

September 12, 2018

Prof Ben Anthony

Today, NLA and Chemical Engineering Department of School of Engineering, NU hosted the  one-day workshop entitled: “Green Energy and Municipal Solid Waste Solutions.”

The workshop was dedicated for the utilization of solid waste in fluidized bed technologies, co-firing in fluidized beds technologies and environmental aspects of municipal solid waste generation.

Scientists from leading universities of neighboring countries and far abroad from the United Kingdom, Russia and Germany, senior management of research organizations, educational institutions, industry representatives, Kazakhstani officials  attended this year’s seminar. The workshop  was moderated by renowned scientists like prof. Ben Anthony, Cranfield University, UK; prof. Georgy Ryabov, All-Russia Thermal Engineering Institute, Russian Federation; Sergey Urcha, LTD “ROP” Waste utility company, Kazakhstan; Christos Venetis, Ingenieurgesellschaft Prof. Czurda und Partner mbH (ICP), Germany and others.

Researchers from NLA and NU presented their project on characterization  and  investigation of energy potential of municipal solid waste in Astana. The objective of this project is to develop fluidized bed co-gasification/combustion technology for refuse-derived fuel and coal. The wider impact from the project is elimination of technical uncertainty barriers preventing correct development of techno-economic feasibility studies necessary for  investment into waste recycling and waste-to-energy facilities in Kazakhstan.

INESS-2018 to be held in NU

INESS-2018 to be held in NU

August 3, 2018

We are glad to announce the 6th International Conference on Nanomaterials and Advanced Energy Storage Systems (INESS-2018) joint with the 10th International Symposium on Inorganic Phosphate Materials 2018 (ISIPM-10),organized by Nazarbayev University (NU), Institute of Batteries (IoB),  National Laboratory Astana (NLA) and Japanese Association of Inorganic Phosphorus Chemistry to be held on August 8-10, 2018 in Astana at Nazarbayev University and cordially invite you to participate!

The joint conference topics cover the following and related areas:


  • Advanced Nanomaterials for Energy Application
  • Advanced Energy Storage, Conversion and Saving Systems
  • Materials for electrochemical sensor and electroanalytical applications
  • Materials and technology for alternative advanced energy applications
  • Catalysis and fuel cells
  • Battery monitoring and management systems
  • Battery safety and utilization
  • Development of electric vehicles and stationary energy storage
  • Modelling tools in materials science and energy conversion systems
  • Energy and environment


  • Basic science of phosphates (Processing of Elaboration, Phosphates Glasses & Glass Ceramics, Structure & Applications, Apatite & Related Bio-Materials, Advanced Structural Analysis, Solid State NMR, Spectroscopy, Synchrotron Radiation)
  • Technology & uses (Anticorrosion & Catalytic Application, Phosphate Materials For Energy, Conversion and Storage)
  • High tech electronics & optics (Electronic Phosphate Materials, Opto-Electronic Materials
  • Beneficiation of Phosphates (Mineral Processes, Technology & Equipment, and Nuclear waste), Phosphoric Acid Purification: Recovery of trace elements (U, Cd, etc.)
  • Phosphate and green Technologies

Full length papers presented at the Conference will be published as Proceedings in international journals.

The researchers from different countries will participate and share their vision on progress and problems in materials science, nanotechnologies, ecology, renewable energy and energy storage systems.

The conference will be supported by several TV, newspaper and internet companies.

The conference is an open event and the participants from academia, industry and investors sectors are welcome to participate. We expect participation of several partner companies, and investors.

The INESS conference started in Nazarbayev University, Kazakhstan in 2013. The scientists and students from Japan, Korea, France, Germany, China, Russia, Canada, UAE, UK, Turkey and Kazakhstan reviewed and discussed the recent progress and problems in materials science, nanotechnologies, ecology, renewable energy, energy storage systems and modeling methods in these fields. For further details please visit the INESS-2018 web-page: For past conferences please check  INESS-2016, INESS-2017.

Looking forward to seeing you at INESS-2018!

Yours sincerely,

Co-Chair of the Organizing Committee

Professor Zhumabay Bakenov,

Director of Center for Energy and Advanced Materials Science

School of Engineering, Nazarbayev University,

Institute of Batteries LLC,

53, Kabanbay Batyr Avenue, Astana 010000 Kazakhstan

Phone: +7 7172 70 65 30; Email:


Gene Therapy for Cancer

Gene Therapy for Cancer

June 20, 2018

On June 12-13, 2018   researchers of National Laboratory Astana with the support of “ALBIOGEN”  company (Moscow, Russia) gave lectures and practical sessions within the framework of "Targeted DNA sequencing from tumor tissues. AmpliSeq ™ for Illumina Cancer Hotspot Panel v2” seminar.

Groups of employees of the Kazakh Scientific Research Institute of Oncology and Radiology (Almaty), and  scientists  from Russia and Belarus  took part in the seminar also.

 The material for the practical stage of the seminar was paraffin blocks with samples of esophageal cancer tissues, thyroid cancer, etc. Participants in the master class  worked on DNA isolation, DNA normalization, preparation and validation of libraries for targeted sequencing, sequencing on the MiSeq platform, as well as launch evaluation and analysis of the data.

It is known that "ALBIOGEN" company since 2015 is the exclusive (sole) official sales representative and distributor of “Illumina” company on the territory of Russia,  Belarus, Kazakhstan and  Uzbekistan. The company's goal is to provide customers with full access to advanced “Illumina” technologies and services, including advanced NGS systems and DNA-biochip analysis, software for bioinformatics and a full range of reagents. The newest products of “Illumina” created together with the world's leading scientists  allow to study the genome at a very deep level and provide an opportunity for innovative achievements in science, medicine and consumer genomics.

“NӘR” synbiotic  to put into production in Astana

“NӘR” synbiotic to put into production in Astana

April 25, 2018

9F6A7657Today,  the first batches of "NӘR" functional food product were produced in a package with an improved design at the milk factory of "Agrofirma Rodina" LLP.
It is known that the synbiotic "NӘR" is the first functional food product created by NLA researchers, which has a number of unique properties, including increases immunity and promotes active longevity. Thus, the therapeutic efficacy of the product in people with diabetes mellitus, hypertension, obesity / overweight, metabolic syndrome and cardiovascular disease has been clinically proven. "НӘР" is also indispensable in the prevention of oncological diseases, including colorectal cancer.
The  synbiotic was created at the Laboratory of the Microbiome and Longevity, NLA, headed by Doctor of Medical Sciences Almagul Kushugulova. And this is the first and unique product of Kazakhstani science, which went into industrial production on the domestic food market.
This was preceded by the painstaking work of NLA researchers and technologists of "Agrofirma Rodina", who conducted industrial approbation of the developed technology for the production of the synbiotic on the basis of a new technological line. All technological regimes were worked out, measures for interaction of technological personnel were adjusted. After the industrial approbation, there was improved the design of the product packaging in order to make it more practical for consumers.
At the launch ceremony there were Ivan Sauer, General Director of the "Agrofirma Rodina", Anuarbek Sultangazin, Chairman of the Board of JSC "Science Foundation"  and Zhaxybay Zhumadilov, Chairman of the Board of "University Medical Center", Nazarbayev University, who previously served as the General Director of NLA and  he is one of the creators of "NӘR."

NU researchers to create electric wheelchairs

NU researchers to create electric wheelchairs

April 24, 2018

 фото по коляскам 2Today, Institute of Batteries, NU and NLA researchers   delivered electric wheelchairs designed to disabled people. Four citizens of Astana were  awarded these electrical drives. This project was realized in conjunction and sponsorship of Institute of Batteries, "Zhan Dosym" Fund and Kazyna Capital Management.


University Medical Center to get  a newly appointed head

University Medical Center to get a newly appointed head

April 10, 2018

20180405095957Professor Zhaxybay Zhumadilov was appointed as  the Chairman of the Board of the Corporate fund “University Medical Center”. Prior to his appointment, Professor Z. Zhumadilov held the position of General Director of  «National Laboratory Astana»PI.

 Zhaxybay Zhumadilov graduated from Semipalatinsk State Medical Institute. In 1990, he defended his doctoral thesis at the Institute of Surgery named after A. Vishnevskiy MSA USSR, Moscow; in 2004 – Ph.D. in Medical Science in Hiroshima University, Japan.

Professor Z. Zhumadilov started his career as a surgeon in the first city hospital in Semipalatinsk. He worked as Head of the Faculty Surgery Department, Pro-Rector of the Semipalatinsk State Medical Institute. In 1999-2004, he worked as a Visiting Professor at Hiroshima University, Japan. From 2004 to 2008, he worked as Pro-Rector on scientific and medical work at the Semipalatinsk State Medical Academy.

From 2008 to 2011, Professor Z. Zhumadilov was the Executive Director of JSC “National Medical Holding” (NMH), Astana, and Rector of the JSC “Medical University of Astana”, and Chairman of the Board of Directors of JSC “Medical University Astana”.

In January 2011, he headed PI “Center for Life Sciences” at Nazarbayev University. Since September 2015, Professor Z. Zhumadilov has been the General Director of  “National Laboratory Astana”, Nazarbayev University.

Prof. Z. Zhumadilov is the author of more than 550 scientific works, including 5 monographs and more than 30 inventions. Over 200 of his works were published in English and Japanese. In addition, he was the head of five doctoral and 22 master theses.

 Z. Zhumadilov is a member of the editorial board of the prestigious American journals “Rejuvenation Research”, “International Journal of Probiotics & Prebiotic”, “Central Asian Journal of Global Health”, and “Gerontology & Geriatrics Research”.

In the 1990s, after the collapse of the USSR, Professor Z. Zhumadilov made a great contribution to the development of healthcare in the region. Through international charitable organizations, he attracted medical equipment and medicines for hospitals. In conjunction with the US Cancer Institute, Professor Z. Zhumadilov worked as a Co-Director of the first international project for screening thyroid diseases, and reconstructing radiation doses in the Semipalatinsk region.

As part of the activities of the international fund “Ecology, Radiation, Health”, Professor Z. Zhumadilov conducted work on attracting American investors to the Semipalatinsk region. Moreover, he did a lot of work on organizing internships in U.S. and Japanese clinics for doctors and nurses of Semipalatinsk.

Professor Z. Zhumadilov was the first in Kazakhstan to start using a fine needle aspiration biopsy method to diagnose nodular thyroid diseases in the regions adjacent to the Semipalatinsk nuclear test site. It was the first time when minimally invasive precision methods for the treatment of nodular thyroid diseases were developed. Together with Japanese scientists, the statuses of thyroid function and iodine deficiency in a number of settlements adjacent to the test site were studied.

 Z. Zhumadilov made a great contribution to the development of science and public health in Kazakhstan. In particular, he was a founder of Nazarbayev University’s Center for Life Sciences, a center with a modern infrastructure to carry out scientific research in accordance with high international standards.

Thanks to the contribution of  Z. Zhumadilov, NU has successfully developed partnerships with the world leaders in biomedicine. Under his guidance, the scientific bases of genomic and personalized medicine, bioinformatics, regenerative and translational medicine in Kazakhstan, as well as the concept of development of the modern paradigm of clinical practice, education and science were developed.

Battery research at Nazarbayev University

Battery research at Nazarbayev University

April 9, 2018
Research Seminar_BakenovOn April 11, Zhumabay Bakenov, Professor, Chemical Engineering, Nazarbayev University; Director, Center for Energy and Advanced Materials Science, National Laboratory Astana will present current projects of his Research Group on preparation and characterization of new materials for next generation rechargeable batteries. 

Prof. Zhumabay Bakenov is an internationally recognized scientist in fields of materials science, electrochemical engineering, and advanced energy storage system. He was the first faculty of the School of Engineering to arrive in August 2011. Since that time, Prof. Bakenov have pro-actively engaged both in the academic and non-academic life of NU, National, and international programs and organizations.

Prof. Bakenov established the largest and successful Research Group at Nazarbayev University, which received a large number of research projects from local and international governmental and industrial funds (EU FP7 Program, World Bank, the Government of Kazakhstan, British Council, National Companies, and international private companies, NU internal funding etc.) with the total requested funding exceeded USD10M. Prof. Bakenov established the first successful startup company at NU, and was the first PI at NU hired international postdocs to his Group.

Don’t miss an opportunity to attend an interesting lecture! 
Date and time: April 11 (Wednesday) at 1:00 pm.
The venue: Nazarbayev University, Block 6, Room # 6.105